Cargando…
Celecoxib Suppresses the Phosphorylation of STAT3 Protein and Can Enhance the Radiosensitivity of Medulloblastoma-Derived Cancer Stem-Like Cells
Medulloblastoma (MB) is a malignant primary brain tumor with poor prognosis. MB-derived CD133/Nestin double-positive cells (MB-DPs) exhibit cancer stem-like cell (CSC)-like properties that may contribute to chemoradioresistance, tumorigenesis and recurrence. In various tumors, signal transducer and...
Autores principales: | Yang, Meng-Yin, Lee, Hsu-Tung, Chen, Chien-Min, Shen, Chiung-Chyi, Ma, Hsin-I |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4100195/ https://www.ncbi.nlm.nih.gov/pubmed/24945311 http://dx.doi.org/10.3390/ijms150611013 |
Ejemplares similares
-
Radiosensitivity enhancement by combined treatment of nimotuzumab and celecoxib on nasopharyngeal carcinoma cells
por: Huang, Jianfeng, et al.
Publicado: (2018) -
Impact of STAT3 phosphorylation in glioblastoma stem cells radiosensitization and patient outcome
por: Masliantsev, Konstantin, et al.
Publicado: (2017) -
Veliparib Is an Effective Radiosensitizing Agent in a Preclinical Model of Medulloblastoma
por: Buck, Jessica, et al.
Publicado: (2021) -
A chemical screen for medulloblastoma identifies quercetin as a putative radiosensitizer
por: Lagerweij, Tonny, et al.
Publicado: (2016) -
Limitations of radiosensitization by direct telomerase inhibition to treat high-risk medulloblastoma
por: Sengupta, Satarupa, et al.
Publicado: (2023)